NOVARTIS AG : Barclays reiterates its Sell rating : vimarsan

In his latest research note, analyst Emily Field confirms his negative recommendation. The broker Barclays is keeping its Sell rating. The target price remains unchanged at CHF 90. | June 5, 2023

Related Keywords

, Barclays , Emily Field , Novartis Ag Stock Exchange , News , Information , Press Release , N , Is , Latest , Research , Analyst , Family , Field , Onfirms , Negative , The , Broker , Us , Keeping , Its , Fell , Target , Price , Remains , Nchanged , It , Chf Novn Ch0012005267 ,